<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02479529</url>
  </required_header>
  <id_info>
    <org_study_id>PI2014_843_0014</org_study_id>
    <secondary_id>2014-002707-22</secondary_id>
    <nct_id>NCT02479529</nct_id>
  </id_info>
  <brief_title>Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.</brief_title>
  <acronym>SNEAD</acronym>
  <official_title>Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After cardiac surgery, vasoplegic syndrome is a hemodynamic state characterized by profound
      hypotension associated with a decrease in systemic vascular resistance. The care of this
      disease is based on the intravenous administration of a vasopressor, usually norepinephrine.
      During the recovery phase, weaning of norepinephrine, is an important step in which any lack
      of preload (blood volume) initial or secondary can be, and increase tissue malperfusion.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The duration of treatment with norepinephrine.</measure>
    <time_frame>Day 28</time_frame>
    <description>Mean duration time of norepinephrine administration calculated in hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The total dose of norepinephrine infused during the study period</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU duration of stay in day</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total urine output in ml during the study period</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total of crystalloid an colloid infused during the study period (ml)</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of arterial lactate at the end of norepinephrine administration</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative atrial arrhythmias (Ac/Fa, Ventricular tachycardia, Ventricular flutter, Ventricular fibrillation) during the study period</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>Day 28</time_frame>
    <description>SOFA score measured at the end of norepinephrine administration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Vasoplegic Syndrome</condition>
  <arm_group>
    <arm_group_label>administration of norepinephrine by dynamic elastance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The norepinephrine weaning strategy is based on an index that reflects the vasomotor tone: dynamic arterial elastance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control administration of norepinephrine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The usual procedure of withdrawal norepinephrine is based on hemodynamic parameters (blood pressure), clinical (cutaneous perfusion, mottling, hourly diuresis) and biological (SVO2, arterial lactate).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Administration and weaning of norepinephrine is based on dynamic arterial elastance</description>
    <arm_group_label>administration of norepinephrine by dynamic elastance</arm_group_label>
    <other_name>Dynamic arterial elastance</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>The usual procedure of withdrawal norepinephrine is based on hemodynamic parameters (blood pressure, cardiac output), clinical (cutaneous perfusion, mottling, hourly diuresis) and biological (SVO2, arterial lactate).</description>
    <arm_group_label>control administration of norepinephrine</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major patient ≥ 18 years

          -  Patient operated a cardiac surgery for myocardial revascularization (CABG surgery) or
             surgical correction of valvular or combined surgery (CABG and valve disease) or
             surgery the ascending aorta and cardiac surgery with vasoplegic syndrome treated by
             norepinephrine

          -  Signed consent

          -  Affiliation to social assurance

        Exclusion Criteria:

          -  Permanent atrial fibrillation

          -  Treatment with dobutamine and/or epinephrine

          -  Pregnant woman

          -  Patient under guardianship or private public law

          -  Internal pacemaker

          -  Hypothermia

          -  Patient refusal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Grégoire Guinot, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens-Picardie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens-Picardie</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Guinot PG, Bernard E, Levrard M, Dupont H, Lorne E. Dynamic arterial elastance predicts mean arterial pressure decrease associated with decreasing norepinephrine dosage in septic shock. Crit Care. 2015 Jan 19;19:14. doi: 10.1186/s13054-014-0732-5.</citation>
    <PMID>25598221</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>October 20, 2016</last_update_submitted>
  <last_update_submitted_qc>October 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasoplegia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

